Cited by 406Peripheral Artery Disease ManagementLipoproteins and Cardiovascular HealthVascular Procedures and Complications

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004

Open access

Pande, Reena L., Perlstein, Todd S., Beckman, Joshua A., Creager, Mark A.·2011·Circulation

DOI 10.1161/circulationaha.110.003954PMC PMC3139992

Open this paper in CoChat — free account

Abstract

Background—: Whether individuals with peripheral artery disease (PAD) identified by screening ankle-brachial index benefit from preventive therapies to reduce cardiovascular risk is unknown. We aimed to determine the number of US adults with PAD who are not receiving preventive therapies and whether treatment is associated with reduced mortality in PAD subjects without known cardiovascular disease. Methods and Results—: We analyzed data from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2004 with mortality follow-up through December 31, 2006. We defined PAD as an ankle-brachial index ≤0.90. Of 7458 eligible participants ≥40 years, weighted PAD prevalence was 5.9±0.3% (mean±SE), corresponding to ≈7.1 million US adults with PAD. Statin use was reported in only 30.5±2.5%, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use in 24.9±1.9%, and aspirin use in 35.8±2.9%, corresponding to 5.0 million adults with PAD not taking statins, 5.4 million not taking angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and 4.5 million not receiving aspirin. After adjustment for age, sex, and race/ethnicity, PAD was associated with all-cause mortality (hazard ratio, 2.4; 95% confidence interval, 1.9 to 2.9; P <0.0001). Even after exclusion of individuals with known cardiovascular disease, subjects with PAD had higher mortality rates (16.1±2.1%) than subjects without PAD or cardiovascular disease (4.1±0.3%), with an adjusted hazard ratio of 1.9 (95% confidence interval, 1.3 to 2.8; P =0.001). Among PAD subjects without cardiovascular disease, use of multiple preventive therapies was associated with 65% lower all-cause mortality (hazard ratio, 0.35; 95% confidence interval, 0.20 to 0.86; P =0.02). Conclusions—: Millions of US adults with PAD are not receiving secondary prevention therapies. Treatment with multiple therapies is associated with reduced all-cause mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.110.003954

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y., Hendriksen, S. M., Kusek, J. W., & Lente, F. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,726
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 4,204
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Self-citation
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Pedersen, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,098

Flagged first, then by citations

Show all 30 references

Sorted by citations

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
Fowkes, F. G. R., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J. O., McDermott, M. M., Norman, P. E., Sampson, U. K., Williams, L. J., Mensah, G. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61249-0 · Cited by 3,508
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.007 · Cited by 1,941
Epidemiology of Peripheral Artery Disease
Criqui, M. H., & Aboyans, V. (2015) · Circulation Research · doi:10.1161/circresaha.116.303849 · Cited by 1,785
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Gerhard‐Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000470 · Cited by 1,093
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Gerhard‐Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000471 · Cited by 1,048
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
Mazzolai, L., Teixidó‐Turà, G., Lanzi, S., Boc, V., Bossone, E., Brodmann, M., Bura-Rivière, A., Backer, J. F. A. D., Déglise, S., Corte, A. D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae179 · Cited by 1,313
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Anand, S. S., Bosch, J., Eikelboom, J. W., Connolly, S. J., Diaz, R., Widimsky, P., Aboyans, V., Alings, M., Kakkar, A. K., Keltai, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32409-1 · Cited by 879
“4,25,26 Consistent benefits in the reduction of major adverse cardiovascular events and major adverse limb events occurred with combination of rivaroxaban 2·5 mg plus aspirin compared with aspirin alone but did not occur to the same extent with the rivaroxaban 5 mg twice a day regimen.”
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association
Criqui, M. H., Matsushita, K., Aboyans, V., Hess, C. N., Hicks, C. W., Kwan, T., McDermott, M. M., Misra, S., & Ujueta, F. (2021) · Circulation · doi:10.1161/cir.0000000000001005 · Cited by 828
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Connolly, S. J., Eikelboom, J. W., Bosch, J., Dagenais, G., Dyal, L., Lanas, F., Metsarinne, K., O'Donnell, M., Dans, A. L., Ha, J.-W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32458-3 · Cited by 754
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation
Vlachopoulos, C., Xaplanteris, P., Aboyans, V., Brodmann, M., Cífková, R., Cosentino, F., De Carlo, M., Gallino, A., Landmesser, U., Laurent, S., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.007 · Cited by 716
Epidemiology of Peripheral Artery Disease and Polyvascular Disease
Aday, A. W., & Matsushita, K. (2021) · Circulation Research · doi:10.1161/circresaha.121.318535 · Cited by 646
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.
Vlachopoulos, C. V., Xaplanteris, P., Aboyans, V., Brodmann, M., Cífková, R., Cosentino, F., Carlo, M. D., Gallino, A., Landmesser, U., Laurent, S., et al. (2015) · HAL · Cited by 590
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary
Gerhard‐Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.008 · Cited by 581
Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men
Joosten, M. M., Pai, J. K., Bertoia, M. L., Rimm, E. B., Spiegelman, D. L., Mittleman, M. A., & Mukamal, K. J. (2012) · JAMA · doi:10.1001/jama.2012.13415 · Cited by 338
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
Kumbhani, D. J., Steg, P. G., Cannon, C. P., Eagle, K. A., Smith, S. C., Goto, S., Ohman, E. M., Elbez, Y., Sritara, P., Baumgartner, I., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu080 · Cited by 318
Self-citation
Cardiac rehabilitation past, present and future: an overview.
Mampuya, W. M. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2012.01.02 · Cited by 336
“suggested in their study that millions of patients with PAD are not receiving secondary prevention therapies (19).”
Background
Vorapaxar in Patients With Peripheral Artery Disease
Bonaca, M. P., Scirica, B. M., Creager, M. A., Olin, J. W., Bounameaux, H. M., Dellborg, M., Lamp, J. M., Murphy, S. A., Braunwald, E., & Morrow, D. A. (2013) · Circulation · doi:10.1161/circulationaha.112.000679 · Cited by 303
Self-citation
2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary
Gerhard‐Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Vascular Medicine · doi:10.1177/1358863x17701592 · Cited by 271
Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease
Arya, S., Khakharia, A., Binney, Z. O., DeMartino, R. R., Brewster, L. P., Goodney, P. P., & Wilson, P. W. F. (2018) · Circulation · doi:10.1161/circulationaha.117.032361 · Cited by 257
Critical Limb Ischemia: Current Trends and Future Directions
Teraa, M., Conte, M. S., Moll, F. L., & Verhaar, M. C. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002938 · Cited by 257
Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
Armstrong, E. J., Chen, D. C., Westin, G. G., Singh, S., McCoach, C. E., Bang, H., Yeo, K. K., Anderson, D. R., Amsterdam, E. A., & Laird, J. R. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000697 · Cited by 254
Peripheral Artery Disease: Past, Present, and Future
Campia, U., Gerhard‐Herman, M. D., Piazza, G., & Goldhaber, S. Z. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.04.043 · Cited by 252
Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review
Agnelli, G., Belch, J. J. F., Baumgärtner, I., Giovas, P. P., & Hoffmann, U. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.09.012 · Cited by 226
Pathophysiology of Intermittent Claudication in Peripheral Artery Disease
Hamburg, N. M., & Creager, M. A. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-1286 · Cited by 225
Self-citation
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia
Almasri, J., Adusumalli, J., Asi, N., Lakis, S., Alsawas, M., Prokop, L. J., Bradbury, A. W., Kolh, P. H., Conte, M. S., & Murad, M. H. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.01.066 · Cited by 222
Peripheral Arterial Disease
Conte, S. M., & Vale, P. R. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.10.014 · Cited by 208
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia
Almasri, J., Adusumalli, J., Asi, N., Lakis, S., Alsawas, M., Prokop, L. J., Bradbury, A. W., Kolh, P. H., Conte, M. S., & Murad, M. H. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.01.071 · Cited by 204
Sex Differences in Peripheral Artery Disease
Pabón, M. A., Cheng, S. C., Altin, S. E., Sethi, S. S., Nelson, M. D., Moreau, K. L., Hamburg, N. M., & Hess, C. N. (2022) · Circulation Research · doi:10.1161/circresaha.121.320702 · Cited by 208
Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia
Westin, G. G., Armstrong, E. J., Bang, H., Yeo, K.-K., Anderson, D., Dawson, D. L., Pevec, W. C., Amsterdam, E. A., & Laird, J. R. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.073 · Cited by 189
Pathogenesis of the Limb Manifestations and Exercise Limitations in Peripheral Artery Disease
Hiatt, W. R., Armstrong, E. J., Larson, C. J., & Brass, E. P. (2015) · Circulation Research · doi:10.1161/circresaha.116.303566 · Cited by 198
Underuse of Prevention and Lifestyle Counseling in Patients With Peripheral Artery Disease
Berger, J. S., & Ladapo, J. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.064 · Cited by 183
Health Disparities in Peripheral Artery Disease: A Scientific Statement From the American Heart Association
Allison, M., Armstrong, D. G., Goodney, P. P., Hamburg, N. M., Kirksey, L., Lancaster, K. J., Mena‐Hurtado, C., Misra, S., Treat‐Jacobson, D., & Solaru, K. W. (2023) · Circulation · doi:10.1161/cir.0000000000001153 · Cited by 187
Peripheral arterial disease, prevalence and cumulative risk factor profile analysis
Eraso, L. H., Fukaya, E., Mohler, E. R., Xie, D., Sha, D., & Berger, J. S. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312452968 · Cited by 180
Peripheral Artery Disease
Olin, J. W., White, C. J., Armstrong, E. J., Kadian‐Dodov, D. L., & Hiatt, W. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.049 · Cited by 180
Missed Opportunities
Subherwal, S., Patel, M. R., Køber, L., Peterson, E. D., Jones, W. S., Gislason, G., Berger, J. S., Torp-Pedersen, C. T., & Fosbøl, E. L. (2012) · Circulation · doi:10.1161/circulationaha.112.108787 · Cited by 168
Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.8357 · Cited by 164
Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030: Time to Get to Our Feet: A Policy Statement From the American Heart Association
Creager, M. A., Matsushita, K., Arya, S., Beckman, J. A., Duval, S., Goodney, P. P., Gutierrez, J. A. T., Kaufman, J. A., Joynt Maddox, K. E., Pollak, A. W., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000967 · Cited by 164
Self-citation
Socioeconomic Inequality and Peripheral Artery Disease Prevalence in US Adults
Pande, R. L., & Creager, M. A. (2014) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000618 · Cited by 154
Self-citation
Racial and Ethnic Disparities in Peripheral Artery Disease
Hackler, E. L., Hamburg, N. M., & White Solaru, K. T. (2021) · Circulation Research · doi:10.1161/circresaha.121.318243 · Cited by 141
The Ankle–Brachial Index for Peripheral Artery Disease Screening and Cardiovascular Disease Prediction Among Asymptomatic Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force
Lin, J. S., Olson, C. M., Johnson, E. S., & Whitlock, E. P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-5-201309030-00007 · Cited by 137
Peripheral Arterial Disease in Women: an Overview of Risk Factor Profile, Clinical Features, and Outcomes
Jelani, Q., Petrov, M., Martinez, S. C., Holmvang, L., Al-Shaibi, K. F., & Alasnag, M. A. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0742-x · Cited by 121
Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease
Allen, N., Barrett, T. J., Guo, Y., Nardi, M. A., Ramkhelawon, B., Rockman, C. R., Hochman, J. S., & Berger, J. S. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.029 · Cited by 119
Pathophysiology of peripheral arterial disease in diabetes mellitus
Yang, S., Zhu, L., Han, R., Sun, L., Li, J., & Dou, J. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12474 · Cited by 119
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization
Sigvant, B., Kragsterman, B., Falkenberg, M., Hasvold, P., Johansson, S., Thuresson, M., & Nordanstig, J. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2016.03.429 · Cited by 108
Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease
Beckman, J. A., Duncan, M. S., Alcorn, C., So‐Armah, K., Butt, A. A., Goetz, M. B., Tindle, H. A., Sico, J. J., Tracy, R. P., Justice, A. C., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032647 · Cited by 106
Self-citation
Pharmacological Treatment and Current Management of Peripheral Artery Disease
Bonaca, M. P., & Creager, M. A. (2015) · Circulation Research · doi:10.1161/circresaha.114.303505 · Cited by 107
Self-citation
Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle–Brachial Index in Adults: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-5-201309030-00008 · Cited by 103
Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization
Hess, C. N., Wang, T. Y., Fu, J. W., Gundrum, J. D., LaPointe, N. M. A., Rogers, R. K., & Hiatt, W. R. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.050 · Cited by 99
Twenty‐Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC)
Tunstall‐Pedoe, H., Peters, S. A. E., Woodward, M., Struthers, A. D., & Belch, J. J. F. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005967 · Cited by 98
Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery
Martino, R. R. D., Eldrup-Jørgensen, J., Nolan, B. W., Stone, D. H., Adams, J., Bertges, D. J., Cronenwett, J. L., & Goodney, P. P. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.12.013 · Cited by 97
Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas
Fanaroff, A. C., Yang, L., Nathan, A. S., Khatana, S. A. M., Julien, H. M., Wang, T. Y., Armstrong, E. J., Treat‐Jacobson, D., Glaser, J. D., Wang, G., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021456 · Cited by 97
Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011–2012
Wong, N. D., Young, D., Zhao, Y., Nguyen, H. A., Caballes, J., Khan, I., & Sanchez, R. J. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.06.011 · Cited by 93
Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document
Cortese, B., Granada, J. F., Scheller, B., Schneider, P. A., Tepe, G., Scheinert, D., Garcia, L. A., Stabile, E., Alfonso, F., Ansel, G. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv204 · Cited by 89
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia
Armstrong, E. J., Chen, D. C., Singh, G. D., Amsterdam, E. A., & Laird, J. R. (2015) · Vascular Medicine · doi:10.1177/1358863x15574321 · Cited by 89
Treatment of hypertension in peripheral arterial disease
Lane, D. A., & Lip, G. Y. H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003075.pub3 · Cited by 91
Medical Therapy in Peripheral Artery Disease
Berger, J. S., & Hiatt, W. R. (2012) · Circulation · doi:10.1161/circulationaha.111.033886 · Cited by 83
Predicting Future Cardiovascular Events in Patients With Peripheral Artery Disease Using Electronic Health Record Data
Ross, E., Jung, K., Dudley, J. T., Li, L., Leeper, N. J., & Shah, N. H. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.004741 · Cited by 83
Adherence to Guideline‐Recommended Therapy—Including Supervised Exercise Therapy Referral—Across Peripheral Artery Disease Specialty Clinics: Insights From the International PORTRAIT Registry
Saxon, J. T., Safley, D. M., Mena-Hurtado, C., Heyligers, J., Fitridge, R., Shishehbor, M., Spertus, J., Gosch, K., Patel, M., & Smolderen, K. (2020) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.119.012541 · Cited by 56
Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK
Soriano, L. C., Fowkes, F. G. R., Johansson, S., Allum, A. M., & Rodríguez, L. A. G. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018184 · Cited by 76
Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease
Armstrong, E. J., Anderson, D. R., Yeo, K. K., Singh, G. D., Bang, H., Amsterdam, E. A., Freischlag, J. A., & Laird, J. R. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.01.051 · Cited by 75
The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis
Enns, J. E., Yeganeh, A., Zarychanski, R., Abou-Setta, A. M., Friesen, C., Zahradka, P. C., & Taylor, C. G. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-70 · Cited by 74
Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study
Sigvant, B., Hasvold, P., Kragsterman, B., Falkenberg, M., Johansson, S., Thuresson, M., & Nordanstig, J. (2017) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.01.067 · Cited by 74
Participation in the Vascular Quality Initiative is associated with improved perioperative medication use, which is associated with longer patient survival
Martino, R. R. D., Hoel, A. W., Beck, A. W., Eldrup-Jørgensen, J., Hallett, J. W., Upchurch, G. R., Cronenwett, J. L., & Goodney, P. P. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.11.073 · Cited by 69
Knowledge of peripheral artery disease: What do the public, healthcare practitioners, and trainees know?
Bridgwood, B. M., Nickinson, A., Houghton, J. S. M., Pepper, C., & Sayers, R. D. (2020) · Vascular Medicine · doi:10.1177/1358863x19893003 · Cited by 68
Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and Outcomes
Srivaratharajah, K., & Abramson, B. L. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.01.009 · Cited by 66
Socioeconomic Disparities in the Use of Cardioprotective Medications Among Patients With Peripheral Artery Disease
Subherwal, S., Patel, M. R., Tang, F., Smolderen, K. G. E., Jones, W. S., Tsai, T. T., Ting, H. H., Bhatt, D. L., Spertus, J. A., & Chan, P. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.018 · Cited by 66
The effect of income and insurance on the likelihood of major leg amputation
Hughes, K., Mota, L., Núñez, M. E. P., Sehgal, N. J., & Ortega, G. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.11.028 · Cited by 62
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia
Almasri, J., Adusumalli, J., Asi, N., Lakis, S., Alsawas, M., Prokop, L. J., Bradbury, A. W., Kolh, P. H., Conte, M. S., & Murad, M. H. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.04.013 · Cited by 59
Readmissions After Revascularization Procedures for Peripheral Arterial Disease
Secemsky, E., Schermerhorn, M., Carroll, B. J., Kennedy, K., Shen, C.-Y., Valsdottir, L. R., Landon, B., & Yeh, R. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1058 · Cited by 61
Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
Rhee, S. Y., & Kim, Y. S. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.283 · Cited by 66
Economic analysis of endovascular interventions for femoropopliteal arterial disease: A systematic review and budget impact model for the United States and Germany
Pietzsch, J. B., Geisler, B. P., Garner, A. M., Zeller, T., & Jaff, M. R. (2014) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25536 · Cited by 57
Cardiovascular and all-cause mortality in patients with intermittent claudication and critical limb ischaemia
van Haelst, S. T. W., Koopman, C., den Ruijter, H. M., Moll, F. L., Visseren, F. L. J., Vaartjes, I. C. H., & de Borst, G. J. (2017) · British journal of surgery · doi:10.1002/bjs.10657 · Cited by 57
The Quality and Impact of Risk Factor Control in Patients With Stable Claudication Presenting for Peripheral Vascular Interventions
Ardati, A. K., Kaufman, S. R., Aronow, H. D., Nypaver, T. J., Bove, P. G., Gurm, H. S., & Grossman, P. M. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.975862 · Cited by 55
Intravascular Ultrasound in Lower Extremity Peripheral Vascular Interventions
Panaich, S., Arora, S., Patel, N., Patel, N., Savani, C., Patel, A., Thakkar, B., Singh, V., Patel, S. D., Patel, N., et al. (2015) · Journal of Endovascular Therapy · doi:10.1177/1526602815620780 · Cited by 54
Hypoxia-Induced miR-210 Modulates Tissue Response to Acute Peripheral Ischemia
Zaccagnini, G., Maimone, B., Stefano, V. D., Fasanaro, P., Greco, S., Perfetti, A., Capogrossi, M. C., Gaetano, C., & Martelli, F. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5206 · Cited by 53
“P eripheral artery disease is a frequent condition, affecting almost 6% of the U.S. population aged ‡ 40 (36), which is mostly caused by stenosis, embolism, or thrombosis involving the arteries supplying the leg (37).”
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs
McBride, C. L., Akeroyd, J. M., Ramsey, D. J., Nambi, V., Nasir, K., Michos, E. D., Bush, R. L., Jneid, H. M., Morris, P. B., Bittner, V., et al. (2018) · Vascular Medicine · doi:10.1177/1358863x18758914 · Cited by 52
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease
Hess, C. N., Cannon, C. P., Beckman, J. A., Goodney, P. P., Patel, M. R., Hiatt, W. R., Mues, K. E., Orroth, K. K., Shannon, E., & Bonaca, M. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.060 · Cited by 54
Self-citation
Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines
Rodríguez, F., Lin, S., Maron, D. J., Knowles, J. W., Virani, S. S., & Heidenreich, P. A. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.09.007 · Cited by 52
Multidisciplinary approach to the diagnosis and management of patients with peripheral arterial disease
Walker, C. M., Bunch, F., Cavros, N. G., & Dippel, E. J. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s79355 · Cited by 50
Comparison Between Endovascular and Open Surgery for the Treatment of Peripheral Artery Diseases: A Meta-Analysis
Tang, Q.-H., Chen, J., Hu, C.-F., & Zhang, X. (2019) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2019.06.039 · Cited by 50
Trends in peripheral arterial disease incidence and mortality in EU15+ countries 1990–2017
Goodall, R. J., Salciccioli, J. D., Davies, A. H., Marshall, D. C., & Shalhoub, J. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319899626 · Cited by 52
Mutually Supportive Mechanisms of Inflammation and Vascular Remodeling
Whiteford, J. R., Rossi, G. D., & Woodfin, A. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.05.001 · Cited by 48
Epidemiology of lower extremity peripheral artery disease in veterans
Willey, J., Mentias, A. G., Vaughan‐Sarrazin, M., McCoy, K. D., Rosenthal, G. E., & Girotra, S. R. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.11.083 · Cited by 48
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial
Berger, J. S., Katona, B. G., Jones, W. S., Patel, M. R., Norgren, L., Baumgartner, I., Blomster, J., Mahaffey, K. W., Held, P., Millegård, M., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.01.018 · Cited by 47
Patterns and predictors of lipid‐lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed‐care population
Steen, D. L., Khan, I., Becker, L. K., Foody, J. M., Gorcyca, K., Sanchez, R. J., & Giugliano, R. P. (2016) · Clinical Cardiology · doi:10.1002/clc.22641 · Cited by 44
Sex Differences in Management and Outcomes of Critical Limb Ischemia in the Medicare Population
Mentias, A. G., Vaughan‐Sarrazin, M., Saad, M. S., & Girotra, S. R. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.009459 · Cited by 43
Statins and Peripheral Arterial Disease: A Narrative Review
Jansen‐Chaparro, S., Lopez-Carmona, M. D., Cobos-Palacios, L., Sanz‐Cánovas, J., Bernal-López, M. R., & Gómez‐Huelgas, R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.777016 · Cited by 50
Contemporary outcomes with percutaneous vascular interventions for peripheral critical limb ischemia in those with and without poly-vascular disease
Krishnamurthy, V. N., Munir, K., Rectenwald, J. E., Mansour, A., Hans, S. S., Eliason, J. L., Escobar, G. A., Gallagher, K. A., Grossman, P. M., Gurm, H. S., et al. (2014) · Vascular Medicine · doi:10.1177/1358863x14552013 · Cited by 42
Barriers to screening and diagnosis of peripheral artery disease by general practitioners
Haigh, K. J., Bingley, J. A., Golledge, J., & Walker, P. J. (2013) · Vascular Medicine · doi:10.1177/1358863x13505673 · Cited by 42
“Vascular Medicine 18(6) 325 –330 © The Author(s) 2013 Reprints and permissions: sagepub.”
Peripheral artery disease
Aboyans, V., Canonico, M. E., Chastaingt, L., Anand, S. S., Brodmann, M., Couffinhal, T., Criqui, M. H., Debus, E. S., Mazzolai, L., McDermott, M. M., et al. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00651-0 · Cited by 50
Utility of Intravascular Ultrasound in Peripheral Vascular Interventions: Systematic Review and Meta-Analysis
Sheikh, A. B., Narayanan, M. A., Smolderen, K. G. E., Jelani, Q., Nagpal, S. V., Schneider, M. D., Llanos‐Chea, F., Ionescu, C., Regan, C. J., Attaran, R., et al. (2020) · Vascular and Endovascular Surgery · doi:10.1177/1538574420920998 · Cited by 41
Lower extremity CT angiography in peripheral arterial disease: from the established approach to evolving technical developments
Shwaiki, O., Rashwan, B., Fink, M. A., Kirksey, L., Gadani, S. D., Karuppasamy, K., Melzig, C., Thompson, D., D’Amico, G., Rengier, F., et al. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02277-1 · Cited by 40
“PAD has a high prevalence, occurring in roughly one in ten individuals above the age of 55 and in up to one in seven individuals above the age of 70; the prevalence has also increased over the past few decades, presumably because of an aging population [3, 5, 6].”
Background
Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease
Chen, D., Armstrong, E. J., Singh, G. D., Amsterdam, E. A., & Laird, J. R. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s76651 · Cited by 39
Endovascular treatment of lower extremity peripheral arterial disease
Klein, A. J., & Ross, C. B. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.02.007 · Cited by 39
Prevalencia y características clínicas de la enfermedad arterial periférica en la población general del estudio Hermex
Félix-Redondo, F. J., Fernandez-Berges, D. J., Grau, M., Baena-Díez, J. M., Mostaza, J. M., & Vila, J. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.03.008 · Cited by 38
Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test
Itoga, N. K., Minami, H. R., Chelvakumar, M., Pearson, K., Mell, M. W., Bendavid, E., & Owens, D. K. (2018) · Vascular Medicine · doi:10.1177/1358863x17745371 · Cited by 38
Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system
Das, S., Singh, G., & Baker, A. B. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.105 · Cited by 38
“ultimately, increased risk for limb amputation [3].”
Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease
Gulizia, M. M., Colivicchi, F., Abrignani, M. G., Ambrosetti, M., Aspromonte, N., Barile, G., Caporale, R., Casolo, G., Chiuini, E., Lenarda, A. D., et al. (2018) · European Heart Journal Supplements · doi:10.1093/eurheartj/suy019 · Cited by 38
Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for Peripheral Artery Disease
Altin, S. E., Castro‐Dominguez, Y., Kennedy, K. F., Orion, K. C., Lansky, A. J., Abbott, J. D., & Aronow, H. D. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.08.036 · Cited by 37
Prescribing of Statins After Lower Extremity Revascularization Procedures in the US
Singh, N., Ding, L., Devera, J., Magee, G. A., & Garg, P. K. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.36014 · Cited by 37

Authors: Pande, R. L., Perlstein, T. S., Beckman, J. A., & Creager, M. A.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Pande, Reena L.
Beckman, Joshua A.
Creager, Mark A.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2011-07-05
Volume: 124
Issue: 1
Pages: 17-23
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.110.003954
PMC: PMC3139992
OpenAlex: W2082336558
Semantic Scholar: 91f0b40eb962eac5bce27896ae06727a10351d5f
Cited by: 406
References: 30
Citations by year: 2026: 13 · 2025: 13 · 2024: 28 · 2023: 31 · 2022: 24 · 2021: 39 · 2020: 33 · 2019: 26 · 2018: 35 · 2017: 26 · 2016: 38 · 2015: 25 · 2014: 21 · 2013: 19 · 2012: 35
FWCI: 24.58
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (K12HL083786, R01HL075771)
Topics: Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
Keywords: peripheral arterial disease, secondary prevention, all-cause mortality, ankle-brachial index, statin use, ACE inhibitors, angiotensin receptor blockers, aspirin, cardiovascular risk reduction, untreated patients
MeSH terms: Aged, Angiotensin-Converting Enzyme Inhibitors, Aspirin, Cardiovascular Diseases, Female, Humans, Male, Nutrition Surveys, Retrospective Studies, Risk Factors, United States, Prevalence, Secondary Prevention, Angiotensin II Type 2 Receptor Blockers, Peripheral Arterial Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks